Waverley Pharma Inc. filed its Annual on Apr 27, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | 0.00% | 0.00% | -40.00% |
Jun. 20 | Waverley Pharma Inc. Elects James Kinley as Director | CI |
May. 29 | Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-40.00% | 595K | |
+20.95% | 127B | |
+23.00% | 117B | |
+25.82% | 27.77B | |
-19.75% | 20.44B | |
-15.03% | 16.62B | |
-16.56% | 15.92B | |
+11.19% | 14.74B | |
-46.65% | 14.94B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- WAVE Stock
- News Waverley Pharma Inc.
- Waverley Pharma Inc. Auditor Raises 'Going Concern' Doubt